Pharmaceuticals market research reports by GlobalData

• Resistant Hypertension (RH) - Competitive Landscape

  Apr 05, 2024  |  Published by: GlobalData  |  USD 3,495

  Resistant Hypertension (RH) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in RH therapeutics. GlobalData epidemiologists estimated more than 79 million diagnosed prevalent cases of RH in 2023 in the 16 countries covered i ... Read More

• Psychedelics Therapeutics Development and Trends, 2024

  Apr 05, 2024  |  Published by: GlobalData  |  USD 495

  Psychedelics Therapeutics Development and Trends, 2024 Summary This report provides a summary of the current and future state of the psychedelic therapeutic sector, offering a high-level analysis of key trends and developments within the industry, including regulatory, clinical, and market dynamics. ... Read More

• Retinitis Pigmentosa (RP) - Competitive Landscape

  Mar 31, 2024  |  Published by: GlobalData  |  USD 3,495

  Retinitis Pigmentosa (RP) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in RP therapeutics. More than 1,000,000 diagnosed prevalent cases of RP are expected in 2024 in the 16 countries covered in GlobalData’s epidemiology ... Read More

• Peripheral Artery Disease (PAD): Competitive Landscape

  Mar 29, 2024  |  Published by: GlobalData  |  USD 3,495

  Peripheral Artery Disease (PAD): Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in PAD therapeutics. More than 18,000,000 diagnosed prevalent cases of PAD are expected in 2024 in the 16 countries covered in GlobalData’s epid ... Read More

• Fuchs Endothelial Corneal Dystrophy (FECD): Competitive Landscape

  Mar 29, 2024  |  Published by: GlobalData  |  USD 3,495

  Fuchs Endothelial Corneal Dystrophy (FECD): Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in FECD therapeutics. More than 133,000,000 total prevalent cases of FECD are expected in 2024 in the 16 countries covered in GlobalD ... Read More

• Breast Implants Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  Mar 29, 2024  |  Published by: GlobalData  |  USD 4,000

  Breast Implants Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Breast Implants Pipeline Report including Stages of Development, Segments, Region and Countries, Regula ... Read More

• Generic Drugs (Physician Perspective) - Thematic Research

  Mar 28, 2024  |  Published by: GlobalData  |  USD 1,495

  Generic Drugs (Physician Perspective) - Thematic Research Summary Generic drugs are touted as an effective cost-containment measure for healthcare systems that often have outdated or ineffective financing mechanisms. By bypassing the extensive clinical studies required for branded medicines, generic ... Read More

• Cell and Gene Therapies in Ophthalmology

  Mar 28, 2024  |  Published by: GlobalData  |  USD 9,995

  Cell and Gene Therapies in Ophthalmology Summary Currently, there are eight cell and gene therapies (CGTs) on the market for various ophthalmology indications. These comprise Spark Therapeutics' Luxturna (voretigene neparvovec), which is indicated for retinitis pigmentosa (retinitis) and Leber conge ... Read More

• Clinical Trials: A Scorecard for Clinical Trial Investigations in 2023

  Mar 27, 2024  |  Published by: GlobalData  |  USD 695

  Clinical Trials: A Scorecard for Clinical Trial Investigations in 2023 Summary This report provides an overview of global clinical trials with a start date between January 1, 2023, and December 31, 2023. Scope The clinical trials data used for these analyses were extracted from GlobalData’s Clinical ... Read More

• Arthralgia (Joint Pain) - Global Clinical Trials Review, 2024

  Mar 25, 2024  |  Published by: GlobalData  |  USD 2,500

  Arthralgia (Joint Pain) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Arthralgia (Joint Pain) - Global Clinical Trials Review, 2024 provides an overview of Arthralgia (Joint Pain) Clinical trials scenario. This report provides top line data relating to the clinic ... Read More

• Obsessive-Compulsive Disorder - Global Clinical Trials Review, 2024

  Mar 25, 2024  |  Published by: GlobalData  |  USD 2,500

  Obsessive-Compulsive Disorder - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Obsessive-Compulsive Disorder - Global Clinical Trials Review, 2024 provides an overview of Obsessive-Compulsive Disorder Clinical trials scenario. This report provides top line data rela ... Read More

• Graft Versus Host Disease (GVHD) - Global Clinical Trials Review, 2024

  Mar 25, 2024  |  Published by: GlobalData  |  USD 2,500

  Graft Versus Host Disease (GVHD) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Graft Versus Host Disease (GVHD) - Global Clinical Trials Review, 2024 provides an overview of Graft Versus Host Disease (GVHD) Clinical trials scenario. This report provides top line ... Read More

• Borderline Personality Disorder (BPD) - Global Clinical Trials Review, 2024

  Mar 25, 2024  |  Published by: GlobalData  |  USD 2,500

  Borderline Personality Disorder (BPD) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Borderline Personality Disorder (BPD) - Global Clinical Trials Review, 2024 provides an overview of Borderline Personality Disorder (BPD) Clinical trials scenario. This report pro ... Read More

• Bronchiectasis - Global Clinical Trials Review, 2024

  Mar 25, 2024  |  Published by: GlobalData  |  USD 2,500

  Bronchiectasis - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Bronchiectasis - Global Clinical Trials Review, 2024 provides an overview of Bronchiectasis Clinical trials scenario. This report provides top line data relating to the clinical trials on Bronchiectasis ... Read More

• Polycystic Kidney Disease - Global Clinical Trials Review, 2024

  Mar 25, 2024  |  Published by: GlobalData  |  USD 2,500

  Polycystic Kidney Disease - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Polycystic Kidney Disease - Global Clinical Trials Review, 2024 provides an overview of Polycystic Kidney Disease Clinical trials scenario. This report provides top line data relating to the ... Read More

• Atopic Dermatitis (Atopic Eczema) - Global Clinical Trials Review, 2024

  Mar 25, 2024  |  Published by: GlobalData  |  USD 2,500

  Atopic Dermatitis (Atopic Eczema) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Atopic Dermatitis (Atopic Eczema) - Global Clinical Trials Review, 2024 provides an overview of Atopic Dermatitis (Atopic Eczema) Clinical trials scenario. This report provides top li ... Read More

• Dry (Atrophic) Macular Degeneration - Global Clinical Trials Review, 2024

  Mar 25, 2024  |  Published by: GlobalData  |  USD 2,500

  Dry (Atrophic) Macular Degeneration - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Dry (Atrophic) Macular Degeneration - Global Clinical Trials Review, 2024 provides an overview of Dry (Atrophic) Macular Degeneration Clinical trials scenario. This report provides ... Read More

• Hyperglycemia - Global Clinical Trials Review, 2024

  Mar 25, 2024  |  Published by: GlobalData  |  USD 2,500

  Hyperglycemia - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Hyperglycemia - Global Clinical Trials Review, 2024 provides an overview of Hyperglycemia Clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperglycemia. Re ... Read More

• Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Global Clinical Trials Review, 2024

  Mar 25, 2024  |  Published by: GlobalData  |  USD 2,500

  Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Global Clinical Trials Review, 2024 provides an overview of Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) Cl ... Read More

• Augmented Reality in Healthcare - Thematic Research

  Mar 22, 2024  |  Published by: GlobalData  |  USD 995

  Augmented Reality in Healthcare - Thematic Research Summary Augmented reality (AR) is a technology that allows the user to see the real world overlaid with digital data. According to GlobalData forecasts, the AR market will be worth $100 billion by 2030, up from $22 billion in 2022. Rather than enab ... Read More

• Current and Future Landscape of RNA-Based Drugs and Impact of COVID-19 Vaccines Success

  Mar 19, 2024  |  Published by: GlobalData  |  USD 495

  Current and Future Landscape of RNA-Based Drugs and Impact of COVID-19 Vaccines Success Summary This report investigates the past, current and future landscape of RNA-Based drugs, and how the success of the COVID-19 vaccines may have impacted this. High level analysis of the key trends and movements ... Read More

• Cell and Gene Therapies in CNS Disorders

  Mar 18, 2024  |  Published by: GlobalData  |  USD 9,995

  Cell and Gene Therapies in CNS Disorders Summary Currently, there are eight cell and gene therapies (CGT) on the market for various central nervous system (CNS) disorders. This includes three gene therapies, two gene-modified cell therapies, and three conditionally approved cell therapies. Novartis’ ... Read More

• Fragile X Syndrome - Global Clinical Trials Review, 2024

  Mar 18, 2024  |  Published by: GlobalData  |  USD 2,500

  Fragile X Syndrome - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Fragile X Syndrome - Global Clinical Trials Review, 2024 provides an overview of Fragile X Syndrome Clinical trials scenario. This report provides top line data relating to the clinical trials on Fr ... Read More

• Online Travel - Thematic Research

  Mar 08, 2024  |  Published by: GlobalData  |  USD 995

  Online Travel - Thematic Research Summary This thematic research report takes an in-depth look at the theme of online travel and the impact it has on the travel and tourism industry. This report analyzes the players impacted by this theme alongside the contributing trends, negative destination trend ... Read More

• Polycystic Ovarian Syndrome (PCOS) - Competitive Landscape

  Mar 08, 2024  |  Published by: GlobalData  |  USD 3,495

  Polycystic Ovarian Syndrome (PCOS) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in PCOS therapeutics. More than 54,000,000 total prevalent cases of PCOS are expected in 2024 in the 16 countries covered in GlobalData’s ep ... Read More

< prev 21 22 23 24 25 26 27 28 29 30 next >